HFS
MCID: HYL004
MIFTS: 42

Hyaline Fibromatosis Syndrome (HFS)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Oral diseases, Rare diseases, Skin diseases

Aliases & Classifications for Hyaline Fibromatosis Syndrome

MalaCards integrated aliases for Hyaline Fibromatosis Syndrome:

Name: Hyaline Fibromatosis Syndrome 57 53 59 75 37 29 13 6 40
Infantile Systemic Hyalinosis 53 25 59 75
Juvenile Hyaline Fibromatosis 53 25 59 75
Hyalinosis, Systemic 57 44 73
Puretic Syndrome 53 25 59
Inherited Systemic Hyalinosis 53 25
Systemic Hyalinosis 25 75
Hfs 57 75
Murray-Puretic-Drescher Syndrome 59
Hyalinosis, Systemic Infantile 55
Neurofibromatosis 1 73
Juvenile Hyalinosis 25
Molluscum Fibrosum 25
Murray Syndrome 25
Ish 75
Jhf 75

Characteristics:

Orphanet epidemiological data:

59
juvenile hyaline fibromatosis
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood;
infantile systemic hyalinosis
Inheritance: Autosomal recessive; Age of onset: Antenatal,Infancy,Neonatal;

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
variable severity
progressive disorder
onset at birth or early in childhood


HPO:

32
hyaline fibromatosis syndrome:
Mortality/Aging death in infancy
Onset and clinical course variable expressivity progressive
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Hyaline Fibromatosis Syndrome

NIH Rare Diseases : 53 Hyaline fibromatosis syndrome (HFS) is a condition characterized by deposits of a clear substance (hyaline) in the skin and in various other body tissues. It typically becomes apparent at birth or in infancy, causing severe pain with movement; progressive joint contractures which limit movement; thickened skin; and hyperpigmented patches over prominences of the joints. Other features may include digestive problems; gum enlargement; skin bumps; pearly papules on the face and neck; and masses near the anus (perianal masses). Complications can be life threatening. Many children with the severe form (previously called infantile systemic hyalinosis) die in early childhood, while some with a milder form (previously called juvenile hyaline fibromatosis) survive into adulthood. HFS is caused by mutations in the ANTXR2 gene and is inherited in an autosomal recessive manner. Treatment is supportive and aims to alleviate pain and other signs and symptoms of the condition.

MalaCards based summary : Hyaline Fibromatosis Syndrome, also known as infantile systemic hyalinosis, is related to hyalinosis systemic short stature and hyalinosis, inherited systemic, and has symptoms including neuralgia An important gene associated with Hyaline Fibromatosis Syndrome is ANTXR2 (ANTXR Cell Adhesion Molecule 2). Affiliated tissues include skin, bone and skeletal muscle, and related phenotypes are macrocephaly and short neck

Genetics Home Reference : 25 Infantile systemic hyalinosis is a disorder that severely affects many areas of the body, including the skin, joints, bones, and internal organs. Hyalinosis refers to the abnormal accumulation of a clear (hyaline) substance in body tissues. The signs and symptoms of this condition are present at birth or develop within the first few months of life. Infantile systemic hyalinosis is characterized by painful skin bumps that frequently appear on the hands, neck, scalp, ears, and nose. They also develop in joint creases and the genital region. These skin bumps may be large or small and often increase in number over time.

OMIM : 57 Hyaline fibromatosis syndrome is an autosomal recessive condition characterized by abnormal growth of hyalinized fibrous tissue usually affecting subcutaneous regions on the scalp, ears, neck, face, hands, and feet. The lesions appear as pearly papules or fleshy nodules. The severity is variable. Some individuals present in infancy and have additional visceral or systemic involvement, which can lead to early death. These patients may show intractable diarrhea and increased susceptibility to infection. Other patients have later onset of a milder disorder affecting only the face and digits. Additional features include gingival hypertrophy, progressive joint contractures resulting in severe limitation of mobility, osteopenia, and osteoporosis. Histologic analysis of skin lesions shows proliferation of spindle-shaped cells forming strands in a homogeneous and hyaline eosinophilic extracellular material in the dermis (summary by Denadai et al., 2012). (228600)

UniProtKB/Swiss-Prot : 75 Hyaline fibromatosis syndrome: An autosomal recessive syndrome characterized by abnormal growth of hyalinized fibrous tissue usually affecting subcutaneous regions on the scalp, ears, neck, face, hands, and feet. The lesions appear as pearly papules or fleshy nodules. Additional features include gingival hypertrophy, progressive joint contractures resulting in severe limitation of mobility, osteopenia, and osteoporosis. Disease severity is variable. Some individuals manifest symptoms in infancy and have additional visceral or systemic involvement. Hyaline deposits in multiple organs, recurrent infections and intractable diarrhea often lead to early death. Surviving children may suffer from severely reduced mobility due to joint contractures. Other patients have later onset of a milder disorder affecting only the face and digits.

Wikipedia : 76 Juvenile hyaline fibromatosis (also known as "Fibromatosis hyalinica multiplex juvenilis,"... more...

Related Diseases for Hyaline Fibromatosis Syndrome

Diseases related to Hyaline Fibromatosis Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 90)
# Related Disease Score Top Affiliating Genes
1 hyalinosis systemic short stature 12.2
2 hyalinosis, inherited systemic 11.6
3 congestive heart failure 11.5
4 hemifacial spasm 11.4
5 hypertrichosis, congenital generalized, with or without gingival hyperplasia 11.4
6 hydrops fetalis, nonimmune 11.2
7 reynolds syndrome 11.1
8 septo-optic dysplasia spectrum 11.1
9 immune hydrops fetalis 11.1
10 fibromatosis 10.7
11 systolic heart failure 10.5
12 esterase c 10.4
13 protein-losing enteropathy 10.3
14 elephantiasis 10.2
15 adamantinoma of long bones 10.2
16 gingival hypertrophy 10.2
17 atrioventricular block 10.1
18 sleep apnea 10.1
19 autosomal recessive disease 10.1
20 oral squamous cell carcinoma 10.1
21 scoliosis 10.1
22 squamous cell carcinoma 10.1
23 bullous pemphigoid 10.1
24 hypertension, essential 10.1
25 autoimmune lymphoproliferative syndrome, type v 10.1
26 lymphoproliferative syndrome 10.1
27 hypertensive heart disease 10.1
28 adenocarcinoma 10.1
29 atrial fibrillation 10.0
30 iron metabolism disease 10.0
31 muscular atrophy 10.0
32 depression 10.0
33 lipoid proteinosis of urbach and wiethe 10.0
34 hemopericardium 10.0
35 pericardial effusion 10.0
36 diarrhea 10.0
37 gingival overgrowth 10.0
38 progressive familial heart block, type ia 10.0
39 cardiac conduction defect 10.0
40 retinoblastoma 10.0
41 resting heart rate, variation in 10.0
42 dilated cardiomyopathy 10.0
43 left bundle branch hemiblock 10.0
44 tricuspid valve insufficiency 10.0
45 central sleep apnea 10.0
46 diastolic heart failure 10.0
47 breast cancer 9.9
48 pheochromocytoma 9.9
49 breath-holding spells 9.9
50 leukemia, chronic myeloid 9.9

Graphical network of the top 20 diseases related to Hyaline Fibromatosis Syndrome:



Diseases related to Hyaline Fibromatosis Syndrome

Symptoms & Phenotypes for Hyaline Fibromatosis Syndrome

Symptoms via clinical synopsis from OMIM:

57
Skeletal:
osteopenia
osteoporosis
osteolysis
joint contractures, progressive

Head And Neck Face:
coarse facies

Abdomen Gastrointestinal:
diarrhea (in severe cases)

Immunology:
recurrent infections (in severe cases)

Head And Neck Mouth:
gingival fibromatosis
gingival hypertrophy

Neurologic Central Nervous System:
normal intelligence

Skin Nails Hair Skin:
painful, fleshy papules or nodules (hands, scalp, ears, perinasal area)
subcutaneous tumors, recurring
hyaline deposition in dermis
proliferation of spindle cells


Clinical features from OMIM:

228600

Human phenotypes related to Hyaline Fibromatosis Syndrome:

59 32 (show all 50)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 macrocephaly 59 32 hallmark (90%) Very frequent (99-80%) HP:0000256
2 short neck 59 32 hallmark (90%) Very frequent (99-80%) HP:0000470
3 osteopenia 59 32 hallmark (90%) Very frequent (99-80%) HP:0000938
4 muscular hypotonia 59 32 hallmark (90%) Very frequent (99-80%) HP:0001252
5 failure to thrive 59 32 hallmark (90%) Very frequent (99-80%) HP:0001508
6 gingival overgrowth 59 32 occasional (7.5%) Occasional (29-5%),Very frequent (99-80%) HP:0000212
7 coarse facial features 59 32 hallmark (90%) Very frequent (99-80%) HP:0000280
8 joint stiffness 59 32 occasional (7.5%) Occasional (29-5%),Very frequent (99-80%) HP:0001387
9 osteoporosis 59 32 hallmark (90%) Very frequent (99-80%) HP:0000939
10 subcutaneous nodule 59 32 hallmark (90%) Very frequent (99-80%),Very frequent (99-80%) HP:0001482
11 immunodeficiency 59 32 hallmark (90%) Very frequent (99-80%) HP:0002721
12 skeletal muscle atrophy 59 32 occasional (7.5%) Occasional (29-5%) HP:0003202
13 feeding difficulties 59 32 hallmark (90%) Very frequent (99-80%) HP:0011968
14 micromelia 59 32 hallmark (90%) Very frequent (99-80%) HP:0002983
15 short palm 59 32 hallmark (90%) Very frequent (99-80%) HP:0004279
16 lymphedema 59 32 hallmark (90%) Very frequent (99-80%) HP:0001004
17 abnormality of the skull 59 32 hallmark (90%) Very frequent (99-80%) HP:0000929
18 skin ulcer 59 32 frequent (33%) Frequent (79-30%),Very frequent (99-80%) HP:0200042
19 telangiectasia of the skin 59 32 hallmark (90%) Very frequent (99-80%) HP:0100585
20 polycystic ovaries 59 32 hallmark (90%) Very frequent (99-80%) HP:0000147
21 aplasia/hypoplasia of the skin 59 32 frequent (33%) Frequent (79-30%) HP:0008065
22 aplasia/hypoplasia of the thymus 59 32 hallmark (90%) Very frequent (99-80%) HP:0010515
23 brachydactyly 59 32 hallmark (90%) Very frequent (99-80%) HP:0001156
24 osteomalacia 59 32 hallmark (90%) Very frequent (99-80%) HP:0002749
25 recurrent fractures 59 32 hallmark (90%) Very frequent (99-80%) HP:0002757
26 chronic diarrhea 59 32 hallmark (90%) Very frequent (99-80%) HP:0002028
27 thickened skin 59 32 hallmark (90%) Very frequent (99-80%) HP:0001072
28 severe short stature 59 32 hallmark (90%) Very frequent (99-80%) HP:0003510
29 urticaria 59 32 hallmark (90%) Very frequent (99-80%) HP:0001025
30 abnormality of dental morphology 59 32 hallmark (90%) Very frequent (99-80%) HP:0006482
31 osteolysis 59 32 occasional (7.5%) Occasional (29-5%) HP:0002797
32 papule 59 32 hallmark (90%) Very frequent (99-80%) HP:0200034
33 camptodactyly of finger 59 32 hallmark (90%) Very frequent (99-80%) HP:0100490
34 abnormality of the hair 59 32 hallmark (90%) Very frequent (99-80%) HP:0001595
35 abnormality of the gastrointestinal tract 59 32 occasional (7.5%) Occasional (29-5%),Very frequent (99-80%) HP:0011024
36 abnormal diaphysis morphology 59 32 hallmark (90%) Very frequent (99-80%) HP:0000940
37 abnormality of the adrenal glands 59 32 hallmark (90%) Very frequent (99-80%) HP:0000834
38 recurrent bacterial infections 59 32 hallmark (90%) Very frequent (99-80%) HP:0002718
39 gingival fibromatosis 59 32 occasional (7.5%) Occasional (29-5%) HP:0000169
40 hyperpigmentation of the skin 59 32 hallmark (90%) Very frequent (99-80%) HP:0000953
41 steatorrhea 59 32 hallmark (90%) Very frequent (99-80%) HP:0002570
42 progressive flexion contractures 59 32 occasional (7.5%) Occasional (29-5%) HP:0005876
43 malabsorption 59 Very frequent (99-80%)
44 death in infancy 59 Frequent (79-30%)
45 growth delay 59 Very frequent (99-80%)
46 abnormality of the face 59 Very frequent (99-80%)
47 abnormality of the musculature 59 Very frequent (99-80%)
48 recurrent infections 32 HP:0002719
49 diarrhea 32 HP:0002014
50 increased susceptibility to fractures 59 Very frequent (99-80%)

UMLS symptoms related to Hyaline Fibromatosis Syndrome:


neuralgia

Drugs & Therapeutics for Hyaline Fibromatosis Syndrome

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Biomarker for Hyaline Fibromatosis Syndrome Recruiting NCT03196115

Search NIH Clinical Center for Hyaline Fibromatosis Syndrome

Cochrane evidence based reviews: hyalinosis, systemic

Genetic Tests for Hyaline Fibromatosis Syndrome

Genetic tests related to Hyaline Fibromatosis Syndrome:

# Genetic test Affiliating Genes
1 Hyaline Fibromatosis Syndrome 29 ANTXR2

Anatomical Context for Hyaline Fibromatosis Syndrome

MalaCards organs/tissues related to Hyaline Fibromatosis Syndrome:

41
Skin, Bone, Skeletal Muscle, Thymus, Lung, Kidney, Heart

Publications for Hyaline Fibromatosis Syndrome

Articles related to Hyaline Fibromatosis Syndrome:

(show all 41)
# Title Authors Year
1
Hyaline fibromatosis syndrome (juvenile hyaline fibromatosis): whole-body MR findings in two siblings with different subcutaneous nodules distribution. ( 29058046 )
2018
2
The genetic basis of hyaline fibromatosis syndrome in patients from a consanguineous background: a case series. ( 29801470 )
2018
3
Two novel mutations in the ANTXR2 gene in a Chinese patient suffering from hyaline fibromatosis syndrome: A case report. ( 30152846 )
2018
4
Hyaline fibromatosis syndrome: Clinical update and phenotype-genotype correlations. ( 30176098 )
2018
5
CMG2/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome. ( 28604699 )
2017
6
Diagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome. ( 28103792 )
2017
7
Erratum to: Diagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome. ( 28148224 )
2017
8
Infantile systemic hyalinosis: a report of two new cases, one with prolonged survival. ( 28524048 )
2017
9
Hyaline fibromatosis syndrome: cutaneous manifestations. ( 27192526 )
2016
10
Hyaline Fibromatosis Syndrome: A Novel Mutation and Recurrent Founder Mutation in the CMG2/ANTXR2 Gene. ( 27174544 )
2016
11
Hyaline Fibromatosis Syndrome: A Rare Inherited Disorder. ( 27688461 )
2016
12
Infantile Systemic Hyalinosis: Novel Founder Mutation in the Initiation Codon among "Malis (Farmers)" in Jodhpur. ( 27753005 )
2016
13
Hyperpigmentation over the metacarpophalangeal joints and the malleoli in a case of hyaline fibromatosis syndrome with ANTXR2 mutations. ( 26335786 )
2015
14
A mild case of hyaline fibromatosis syndrome, presenting in an adult. ( 25809500 )
2015
15
Hyaline fibromatosis syndrome with mutation c.1074delT of the CMG2 gene: a case report. ( 25186005 )
2014
16
Hyaline fibromatosis of Hoffa's fat pad in a patient with a mild type of hyaline fibromatosis syndrome. ( 24132693 )
2013
17
In-depth analysis of hyaline fibromatosis syndrome frameshift mutations at the same site reveal the necessity of personalized therapy. ( 23554269 )
2013
18
Hyaline fibromatosis syndrome resulting from a new homozygous missense mutation, p.Gly116Val, in ANTXR2. ( 23734713 )
2013
19
Hyaline fibromatosis syndrome: new unifying term and surgical approach. ( 22771664 )
2012
20
Identification of 2 novel ANTXR2 mutations in patients with hyaline fibromatosis syndrome and proposal of a modified grading system. ( 22383261 )
2012
21
Juvenile hyaline fibromatosis or hyaline fibromatosis syndrome? ( 23455832 )
2012
22
Hyaline fibromatosis syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors. ( 21328543 )
2011
23
Heterogeneity and atypical presentation in infantile systemic hyalinosis with severe labio-gingival enlargement: first Egyptian report. ( 19624984 )
2009
24
The anesthetic management of a child with infantile systemic hyalinosis. ( 18673317 )
2008
25
Thick skin, nodules, and immobility in an infant. Infantile systemic hyalinosis. ( 18950399 )
2008
26
Infantile systemic hyalinosis: report of three Iranian children and review of the literature. ( 16328093 )
2007
27
Anthrax toxin receptors and infantile systemic hyalinosis. ( 17280935 )
2007
28
Infantile systemic hyalinosis: a case report and mutation analysis in a Chinese infant. ( 17300268 )
2007
29
Infantile systemic hyalinosis with early thyroid dysfunction. ( 17849746 )
2007
30
Infantile systemic hyalinosis: a fatal disorder commonly diagnosed among Arabs. ( 16173255 )
2005
31
Infantile systemic hyalinosis. ( 14726869 )
2004
32
Infantile systemic hyalinosis: a clinicopathological study. ( 15326628 )
2004
33
Infantile systemic hyalinosis. ( 14501336 )
2003
34
Skeletal muscle involvement in infantile systemic hyalinosis. ( 14623219 )
2003
35
Infantile systemic hyalinosis in siblings: clinical report, biochemical and ultrastructural findings, and review of the literature. ( 11298373 )
2001
36
Infantile systemic hyalinosis: a case with atypical prolonged survival. ( 11440109 )
2001
37
Oral manifestations of infantile systemic hyalinosis. ( 7539846 )
1995
38
Infantile systemic hyalinosis in a black infant. ( 7513419 )
1994
39
Clinical, histologic, and ultrastructural findings in two cases of infantile systemic hyalinosis. ( 1488375 )
1992
40
Infantile systemic hyalinosis: newly recognized disorder of collagen? ( 1702887 )
1991
41
Infantile systemic hyalinosis: report of four cases of a disease, fatal in infancy, apparently different from juvenile systemic hyalinosis. ( 2434938 )
1986

Variations for Hyaline Fibromatosis Syndrome

UniProtKB/Swiss-Prot genetic disease variations for Hyaline Fibromatosis Syndrome:

75
# Symbol AA change Variation ID SNP ID
1 ANTXR2 p.Leu45Pro VAR_022687 rs886041401
2 ANTXR2 p.Gly105Asp VAR_022688 rs137852902
3 ANTXR2 p.Ile189Thr VAR_022689 rs137852905
4 ANTXR2 p.Cys218Arg VAR_022690 rs781637328
5 ANTXR2 p.Leu329Arg VAR_022692 rs137852903
6 ANTXR2 p.Tyr381Cys VAR_022694 rs137852901

ClinVar genetic disease variations for Hyaline Fibromatosis Syndrome:

6 (show top 50) (show all 89)
# Gene Variation Type Significance SNP ID Assembly Location
1 ANTXR2 NM_058172.5(ANTXR2): c.1179G> A (p.Glu393=) single nucleotide variant Pathogenic rs546102223 GRCh37 Chromosome 4, 80905032: 80905032
2 ANTXR2 NM_058172.5(ANTXR2): c.1179G> A (p.Glu393=) single nucleotide variant Pathogenic rs546102223 GRCh38 Chromosome 4, 79983878: 79983878
3 ANTXR2 NM_058172.5(ANTXR2): c.1142A> G (p.Tyr381Cys) single nucleotide variant Pathogenic rs137852901 GRCh37 Chromosome 4, 80905069: 80905069
4 ANTXR2 NM_058172.5(ANTXR2): c.1142A> G (p.Tyr381Cys) single nucleotide variant Pathogenic rs137852901 GRCh38 Chromosome 4, 79983915: 79983915
5 ANTXR2 NM_058172.5(ANTXR2): c.314G> A (p.Gly105Asp) single nucleotide variant Pathogenic rs137852902 GRCh37 Chromosome 4, 80977150: 80977150
6 ANTXR2 NM_058172.5(ANTXR2): c.314G> A (p.Gly105Asp) single nucleotide variant Pathogenic rs137852902 GRCh38 Chromosome 4, 80055996: 80055996
7 ANTXR2 NM_058172.5(ANTXR2): c.986T> G (p.Leu329Arg) single nucleotide variant Pathogenic rs137852903 GRCh37 Chromosome 4, 80929730: 80929730
8 ANTXR2 NM_058172.5(ANTXR2): c.986T> G (p.Leu329Arg) single nucleotide variant Pathogenic rs137852903 GRCh38 Chromosome 4, 80008576: 80008576
9 ANTXR2 NM_058172.5(ANTXR2): c.658G> T (p.Glu220Ter) single nucleotide variant Pathogenic rs137852904 GRCh37 Chromosome 4, 80957165: 80957165
10 ANTXR2 NM_058172.5(ANTXR2): c.658G> T (p.Glu220Ter) single nucleotide variant Pathogenic rs137852904 GRCh38 Chromosome 4, 80036011: 80036011
11 ANTXR2 NM_058172.5(ANTXR2): c.566T> C (p.Ile189Thr) single nucleotide variant Pathogenic rs137852905 GRCh37 Chromosome 4, 80975496: 80975496
12 ANTXR2 NM_058172.5(ANTXR2): c.566T> C (p.Ile189Thr) single nucleotide variant Pathogenic rs137852905 GRCh38 Chromosome 4, 80054342: 80054342
13 ANTXR2 NM_058172.5(ANTXR2): c.1073dupC (p.Ala359Cysfs) duplication Pathogenic rs312262690 GRCh37 Chromosome 4, 80905986: 80905986
14 ANTXR2 NM_058172.5(ANTXR2): c.1073dupC (p.Ala359Cysfs) duplication Pathogenic rs312262690 GRCh38 Chromosome 4, 79984832: 79984832
15 ANTXR2 ANTXR2, 1-BP DEL, 1074T deletion Pathogenic
16 ANTXR2 NM_058172.5(ANTXR2): c.1305delC (p.Thr436Hisfs) deletion Pathogenic rs797045028 GRCh38 Chromosome 4, 79978049: 79978049
17 ANTXR2 NM_058172.5(ANTXR2): c.1305delC (p.Thr436Hisfs) deletion Pathogenic rs797045028 GRCh37 Chromosome 4, 80899203: 80899203
18 ANTXR2 NM_058172.5(ANTXR2): c.241T> C (p.Ser81Pro) single nucleotide variant Likely pathogenic rs797045029 GRCh37 Chromosome 4, 80990645: 80990645
19 ANTXR2 NM_058172.5(ANTXR2): c.241T> C (p.Ser81Pro) single nucleotide variant Likely pathogenic rs797045029 GRCh38 Chromosome 4, 80069491: 80069491
20 ANTXR2 NM_058172.5(ANTXR2): c.1148G> A (p.Gly383Asp) single nucleotide variant Likely pathogenic rs886039907 GRCh37 Chromosome 4, 80905063: 80905063
21 ANTXR2 NM_058172.5(ANTXR2): c.1148G> A (p.Gly383Asp) single nucleotide variant Likely pathogenic rs886039907 GRCh38 Chromosome 4, 79983909: 79983909
22 ANTXR2 NM_058172.5(ANTXR2): c.1392C> A (p.Asp464Glu) single nucleotide variant Uncertain significance rs770869771 GRCh38 Chromosome 4, 79977657: 79977657
23 ANTXR2 NM_058172.5(ANTXR2): c.1392C> A (p.Asp464Glu) single nucleotide variant Uncertain significance rs770869771 GRCh37 Chromosome 4, 80898811: 80898811
24 ANTXR2 NM_058172.5(ANTXR2): c.378+8A> C single nucleotide variant Benign rs4594664 GRCh38 Chromosome 4, 80055924: 80055924
25 ANTXR2 NM_058172.5(ANTXR2): c.378+8A> C single nucleotide variant Benign rs4594664 GRCh37 Chromosome 4, 80977078: 80977078
26 ANTXR2 NM_058172.5(ANTXR2): c.252G> A (p.Val84=) single nucleotide variant Uncertain significance rs886059657 GRCh38 Chromosome 4, 80069480: 80069480
27 ANTXR2 NM_058172.5(ANTXR2): c.252G> A (p.Val84=) single nucleotide variant Uncertain significance rs886059657 GRCh37 Chromosome 4, 80990634: 80990634
28 ANTXR2 NM_058172.5(ANTXR2): c.225-4G> A single nucleotide variant Likely benign rs141355689 GRCh38 Chromosome 4, 80069511: 80069511
29 ANTXR2 NM_058172.5(ANTXR2): c.225-4G> A single nucleotide variant Likely benign rs141355689 GRCh37 Chromosome 4, 80990665: 80990665
30 ANTXR2 NM_058172.5(ANTXR2): c.-82C> A single nucleotide variant Benign rs13140055 GRCh38 Chromosome 4, 80072642: 80072642
31 ANTXR2 NM_058172.5(ANTXR2): c.-82C> A single nucleotide variant Benign rs13140055 GRCh37 Chromosome 4, 80993796: 80993796
32 ANTXR2 NM_058172.5(ANTXR2): c.-230_-229delAA deletion Benign rs80314910 GRCh38 Chromosome 4, 80072789: 80072790
33 ANTXR2 NM_058172.5(ANTXR2): c.-230_-229delAA deletion Benign rs80314910 GRCh37 Chromosome 4, 80993943: 80993944
34 ANTXR2 NM_058172.5(ANTXR2): c.-410G> A single nucleotide variant Likely benign rs72869605 GRCh37 Chromosome 4, 80994124: 80994124
35 ANTXR2 NM_058172.5(ANTXR2): c.-410G> A single nucleotide variant Likely benign rs72869605 GRCh38 Chromosome 4, 80072970: 80072970
36 ANTXR2 NM_058172.5(ANTXR2): c.-442C> G single nucleotide variant Uncertain significance rs886059663 GRCh37 Chromosome 4, 80994156: 80994156
37 ANTXR2 NM_058172.5(ANTXR2): c.-442C> G single nucleotide variant Uncertain significance rs886059663 GRCh38 Chromosome 4, 80073002: 80073002
38 ANTXR2 NM_058172.5(ANTXR2): c.-455C> T single nucleotide variant Uncertain significance rs886059664 GRCh37 Chromosome 4, 80994169: 80994169
39 ANTXR2 NM_058172.5(ANTXR2): c.-455C> T single nucleotide variant Uncertain significance rs886059664 GRCh38 Chromosome 4, 80073015: 80073015
40 ANTXR2 NM_058172.5(ANTXR2): c.1069G> C (p.Ala357Pro) single nucleotide variant Benign rs12647691 GRCh38 Chromosome 4, 79984836: 79984836
41 ANTXR2 NM_058172.5(ANTXR2): c.1069G> C (p.Ala357Pro) single nucleotide variant Benign rs12647691 GRCh37 Chromosome 4, 80905990: 80905990
42 ANTXR2 NM_058172.5(ANTXR2): c.1068C> A (p.Pro356=) single nucleotide variant Likely benign rs72653288 GRCh38 Chromosome 4, 79984837: 79984837
43 ANTXR2 NM_058172.5(ANTXR2): c.1068C> A (p.Pro356=) single nucleotide variant Likely benign rs72653288 GRCh37 Chromosome 4, 80905991: 80905991
44 ANTXR2 NM_058172.5(ANTXR2): c.745C> T (p.Arg249Trp) single nucleotide variant Uncertain significance rs377185226 GRCh38 Chromosome 4, 80033523: 80033523
45 ANTXR2 NM_058172.5(ANTXR2): c.745C> T (p.Arg249Trp) single nucleotide variant Uncertain significance rs377185226 GRCh37 Chromosome 4, 80954677: 80954677
46 ANTXR2 NM_058172.5(ANTXR2): c.637-10dupT duplication Uncertain significance rs776155948 GRCh38 Chromosome 4, 80036042: 80036042
47 ANTXR2 NM_058172.5(ANTXR2): c.637-10dupT duplication Uncertain significance rs776155948 GRCh37 Chromosome 4, 80957196: 80957196
48 ANTXR2 NM_058172.5(ANTXR2): c.324T> C (p.Asp108=) single nucleotide variant Uncertain significance rs184413338 GRCh38 Chromosome 4, 80055986: 80055986
49 ANTXR2 NM_058172.5(ANTXR2): c.324T> C (p.Asp108=) single nucleotide variant Uncertain significance rs184413338 GRCh37 Chromosome 4, 80977140: 80977140
50 ANTXR2 NM_058172.5(ANTXR2): c.233T> C (p.Met78Thr) single nucleotide variant Uncertain significance rs886059658 GRCh38 Chromosome 4, 80069499: 80069499

Expression for Hyaline Fibromatosis Syndrome

Search GEO for disease gene expression data for Hyaline Fibromatosis Syndrome.

Pathways for Hyaline Fibromatosis Syndrome

GO Terms for Hyaline Fibromatosis Syndrome

Sources for Hyaline Fibromatosis Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....